COM:SPRINGWORKSTX
SpringWorks Therapeutics
- Stock
Last Close
37.44
21/11 21:00
Market Cap
2.93B
Beta: -
Volume Today
1.23M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|
net income | -17.81M - | -58.31M 227.32% | -45.57M 21.84% | -173.91M 281.60% | -277.42M 59.52% | -325.10M 17.19% | |
depreciation and amortization | 17K - | 192K 1,029.41% | 349K 81.77% | 490K 40.40% | 765K 56.12% | 1.67M 117.91% | |
deferred income tax | 605K - | 988K 63.31% | 9.23M - | ||||
stock based compensation | 1.07M - | 3.11M 190.83% | 10.03M 222.74% | 38.44M 283.14% | 72.97M 89.80% | 94.53M 29.56% | |
change in working capital | 2.02M - | 4.95M 144.78% | 1.35M 72.79% | 5.12M 280.24% | 38.10M 644.49% | -583K 101.53% | |
accounts receivables | -5.93M - | ||||||
inventory | -3.10M - | ||||||
accounts payables | 491K - | 1.88M 282.89% | -1.30M 169.36% | 2.07M 259.05% | 4.17M 100.96% | -196K 104.70% | |
other working capital | 1.53M - | 3.07M 100.46% | 2.65M 13.60% | 3.04M 14.87% | 33.94M 1,014.82% | 9.23M 72.80% | |
other non cash items | 2.61M - | 1.05M 59.87% | 993K 5.34% | 4.02M 304.93% | -2.54M 163.12% | ||
net cash provided by operating activities | -14.71M - | -47.44M 222.62% | -32.19M 32.15% | -127.88M 297.24% | -161.56M 26.34% | -222.79M 37.90% | |
investments in property plant and equipment | -293K - | -670K 128.67% | -642K 4.18% | -2.02M 214.02% | -10.20M 405.75% | -7.38M 27.57% | |
acquisitions net | -3.59M - | -3.50M 2.51% | 2.02M 157.60% | -4.20M 308.33% | -2.80M 33.33% | ||
purchases of investments | -3.59M - | -442.69M 12,231.20% | -305.42M 31.01% | -481.05M 57.50% | -575.72M 19.68% | ||
sales maturities of investments | 3.59M - | 28M 679.17% | 391.03M 1,296.54% | 279.85M 28.43% | 620.66M 121.78% | ||
other investing activites | -3.59K - | -2.02M - | |||||
net cash used for investing activites | -293K - | -4.26M 1,353.92% | -418.83M 9,731.74% | 83.59M 119.96% | -215.60M 357.92% | 34.75M 116.12% | |
debt repayment | |||||||
common stock issued | 169.73M - | 269.59M 58.84% | 1.16M 99.57% | 340.07M 29,292.05% | 299.30M 11.99% | ||
common stock repurchased | -1.34M - | -2.80M 108.80% | |||||
dividends paid | |||||||
other financing activites | 50.38M - | 163.98M 225.51% | 893K 99.46% | 1.98M - | 139K 92.97% | ||
net cash used provided by financing activities | 50.38M - | 333.71M 562.43% | 270.49M 18.95% | 1.16M 99.57% | 340.70M 29,347.02% | 296.64M 12.93% | |
effect of forex changes on cash | |||||||
net change in cash | 35.38M - | 282.00M 697.14% | -180.54M 164.02% | -43.13M 76.11% | -36.46M 15.47% | 108.60M 397.87% | |
cash at beginning of period | 10.27M - | 46.19M 349.69% | 328.19M 610.56% | 147.65M 55.01% | 104.53M 29.21% | 68.07M 34.88% | |
cash at end of period | 45.65M - | 328.19M 618.96% | 147.65M 55.01% | 104.53M 29.21% | 68.07M 34.88% | 176.67M 159.54% | |
operating cash flow | -14.71M - | -47.44M 222.62% | -32.19M 32.15% | -127.88M 297.24% | -161.56M 26.34% | -222.79M 37.90% | |
capital expenditure | -293K - | -670K 128.67% | -642K 4.18% | -2.02M 214.02% | -10.20M 405.75% | -7.38M 27.57% | |
free cash flow | -15.00M - | -48.11M 220.78% | -32.83M 31.76% | -129.89M 295.62% | -171.76M 32.23% | -230.18M 34.01% |
All numbers in (except ratios and percentages)